PL
XPO icon

Pluribus Labs’s XPO XPO Stock Holding History

Pluribus Labs’s Portfolio XPO Stock Details XPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,318
Closed -$245K – 224
2021
Q4 		$245K Buy
+5,318
New +$247K 0.26% 174

Other funds holding XPO

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ACM
Anomaly Capital Management New York $1.65B AUM 26.47% 1-Year Est. Return

Pluribus Labs's XPO Position: Q1 2022 in Review

Pluribus Labs sold out of XPO (XPO) in Q1 2022, closing a stake of 5,318 shares — an estimated $245K sold.

Pluribus Labs first reported a position in XPO in Q4 2021 and held it in 1 quarter. The position peaked at $245K in Q4 2021. 463 funds tracked by Wall St. Rank hold XPO as of Q1 2022.

  • Pluribus Labs reported no remaining XPO position as of Q1 2022 after selling out during the quarter.
  • Pluribus Labs sold 5,318 XPO shares in Q1 2022, an estimated $245K.
  • Pluribus Labs first reported a position in XPO in Q4 2021 and held it in 1 quarter.
  • Pluribus Labs's XPO position peaked at $245K in Q4 2021.
  • 463 funds tracked by Wall St. Rank held XPO as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.